Vincent Hennemand
Head of Sail Biomedicines’ CAR Franchise Sail Biomedicines
Seminars
Tuesday 22nd July 2025
Panel Discussion: Harnessing the Potential of mRNA & Circular RNA Technology as a Tool to Advance In Vivo Engineering Cell & CAR-T Therapy
9:45 am
